April 9th-15th is Orchid Male Cancer awareness week. Menarini Diagnostics are proud to offer key prostate antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

Prostate cancer is the most common cancer in the UK in males, with about 26% of new cancer cases in men classified as prostatic, contributing to approximately 13% of cancer deaths yearly (1). Menarini Diagnostics offer key antibodies that may aid identification of their respective proteins by IHC in FFPE tissues. Take a look at the antibody factsheet linked below which details more information on the antibodies we offer.

Prostate Cancer Anitbody Factsheet 

(1) Cancer Research UK (2014 and 2015), http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer